Ms. Wu et al., Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer, GENE CHROM, 30(1), 2001, pp. 80-86
To characterize phenotypic and genotypic changes in gastric cancer (GC), DN
A copy number aberrations (CNAs) were assessed in 53 tumors using comparati
ve genomic hybridization (CGH) and correlated with clinicopathologic charac
teristics and status of TP53 and replication error (RER). The number of CNA
s per tumor was 6.8 (gain 5.3, loss 1.5), and the number of changes was sig
nificantly higher in tumors with advanced stage, TP53 mutation, and without
RER than in those with early stage (7.7 vs. 3.0), no TP53 mutations (12.4
vs. 4.8) or RER phenotype (8.2 vs. 2.6). Frequent abnormalities included ga
ins on chromosomal arms 8q (43%), 6q (26%), 11q(26%), 13q (24%), 7p (23%),
17q (23%), and 20q (23%), and losses on chromosomal arms I bq (26%), 19p (2
3%), 5q (19%), 3p (15%), 4q(15%), and Ip (15%). Advanced GC demonstrated a
higher prevalence of gains of 8q (51% vs. 10%, P < 0.05) and loss of 16q (3
3% vs. 0%, P < 0.05) than early GC. Gains on 8q (64% vs. 20%, P < 0.05), 17
q (39% vs. 4%, P < 0.05) and losses on 3p (25% vs. 4%, P = 0.05) and 5q (32
% vs. 4%, 8 < 0.05) were higher in intestinal GC than in diffuse GC. On the
other hand, gains on 13q were more common in the diffuse type (40% vs. 11%
, 8 < 0.05). As compared with noncardia cancer, cardia cancer showed more g
ains on 7p (58% vs. 12%, 8 < 0.05) and 20q (58% vs. 12%, 8 < 0.05) and more
losses on 4q (50% vs. 5%, 8 < 0.05). The finding of histology-related aber
rations and the combination of CGH and molecular data thus provide addition
al evidence suggesting genetic heterogeneity of GC. (C) 2001 Wiley-Liss, In
c.